Overview

Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
A single-center, prospective randomized study. Consecutive patients presenting with intertrochanteric hip fractures will be treated with tranexamic acid. Treatment will be initiated in the emergency department according to a previously studied protocol for trauma patients.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Tranexamic Acid